Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial
阿特珠单抗联合贝伐珠单抗治疗微卫星不稳定性样转移性结直肠癌的疗效和安全性:一项多中心、单臂、II期、开放标签临床试验
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105892
Elez, E; Siena, S; Sartore-Bianchi, A; Ros, J; Ciardello, F; Martinelli, E; Steeghs, N; Huijberts, S; Cervantes, A; Roselló, S; Tejpar, S; Wilmsen, B; Salazar, R; Santos, C; de Schaetzen, G; Muñoz, S; Bernards, R; Moreno, V; García-Galera, E; Alemany, R; Gros, A; Bardelli, A; Arena, S; Piris, A; Chavarría, E; Dienstmann, R; Tabernero, J